• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Cancer metastasis may increase COVID-19 mortality: Suitable targets required to impede cancer metastasis.

作者信息

Mohiuddin Md, Kasahara Kazuo

机构信息

Department of Respiratory Medicine, Kanazawa University, Ishikawa, Japan.

Department of Respiratory Medicine, Kanazawa University, Ishikawa, Japan.

出版信息

J Infect Public Health. 2022 Feb;15(2):153-155. doi: 10.1016/j.jiph.2021.12.004. Epub 2021 Dec 10.

DOI:10.1016/j.jiph.2021.12.004
PMID:34929552
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8662903/
Abstract
摘要

相似文献

1
Cancer metastasis may increase COVID-19 mortality: Suitable targets required to impede cancer metastasis.癌症转移可能会增加COVID-19的死亡率：需要合适的靶点来阻止癌症转移。
J Infect Public Health. 2022 Feb;15(2):153-155. doi: 10.1016/j.jiph.2021.12.004. Epub 2021 Dec 10.
2
High mortality rate in cancer patients with symptoms of COVID-19 with or without detectable SARS-COV-2 on RT-PCR.癌症患者出现 COVID-19 症状，无论 RT-PCR 是否检测到 SARS-COV-2，死亡率均较高。
Eur J Cancer. 2020 Aug;135:251-259. doi: 10.1016/j.ejca.2020.05.028. Epub 2020 Jun 7.
3
Safety of systemic anti-cancer treatment in oncology patients with non-severe COVID-19: a cohort study.伴有非重症 COVID-19 的肿瘤患者接受全身性抗癌治疗的安全性：一项队列研究。
BMC Cancer. 2021 May 20;21(1):578. doi: 10.1186/s12885-021-08349-8.
4
Structure-based virtual screening and molecular dynamics simulation of SARS-CoV-2 Guanine-N7 methyltransferase (nsp14) for identifying antiviral inhibitors against COVID-19.基于结构的 SARS-CoV-2 鸟嘌呤-N7 甲基转移酶（nsp14）的虚拟筛选和分子动力学模拟，以鉴定针对 COVID-19 的抗病毒抑制剂。
J Biomol Struct Dyn. 2021 Aug;39(13):4582-4593. doi: 10.1080/07391102.2020.1778535. Epub 2020 Jun 22.
5
SARS-CoV-2 as a mimicker of pulmonary metastasis in osteosarcoma.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）作为骨肉瘤肺转移的模仿者。
Pediatr Blood Cancer. 2022 Jun;69(6):e29435. doi: 10.1002/pbc.29435. Epub 2021 Nov 12.
6
SARS-CoV-2 in pediatric cancer: a systematic review.儿童癌症中的 SARS-CoV-2：系统综述。
Eur J Pediatr. 2022 Apr;181(4):1413-1427. doi: 10.1007/s00431-021-04338-y. Epub 2022 Jan 10.
7
Preexisting and Post-COVID-19 Immune Responses to SARS-CoV-2 in Patients with Cancer.癌症患者对 SARS-CoV-2 的预先存在和 COVID-19 后免疫反应。
Cancer Discov. 2021 Aug;11(8):1982-1995. doi: 10.1158/2159-8290.CD-21-0191. Epub 2021 May 19.
8
The COVID-19 susceptibility of cancer patients might due to the high expression of SARS-CoV-2 required host factors.癌症患者对新冠病毒的易感性可能归因于新冠病毒所需宿主因子的高表达。
J Infect. 2022 Mar;84(3):418-467. doi: 10.1016/j.jinf.2021.12.011. Epub 2021 Dec 22.
9
Severity and 1-month outcome of SARS-CoV-2 infection in patients with solid cancers: a Danish nationwide cohort study.实体瘤癌症患者感染 SARS-CoV-2 的严重程度和 1 个月预后：一项丹麦全国队列研究。
Acta Oncol. 2021 Jul;60(7):859-865. doi: 10.1080/0284186X.2021.1889659. Epub 2021 Mar 1.
10
COVID-19 in cancer patients: clinical characteristics and outcome-an analysis of the LEOSS registry.癌症患者中的 COVID-19：临床特征和结局——LEOSS 登记处的分析。
Ann Hematol. 2021 Feb;100(2):383-393. doi: 10.1007/s00277-020-04328-4. Epub 2020 Nov 7.

引用本文的文献

1
Is there a rationale for hyperbaric oxygen therapy in the patients with Post COVID syndrome? : A critical review.高压氧疗法在新冠后遗症患者中的应用是否合理？：一项批判性综述。
Eur Arch Psychiatry Clin Neurosci. 2024 Dec;274(8):1797-1817. doi: 10.1007/s00406-024-01911-y. Epub 2024 Nov 15.
2
Bayesian Inference for High Dimensional Cox Models with Gaussian and Diffused-Gamma Priors: A Case Study of Mortality in COVID-19 Patients Admitted to the ICU.具有高斯和扩散伽马先验的高维考克斯模型的贝叶斯推断：以入住重症监护病房的COVID-19患者死亡率为例的研究
Stat Biosci. 2024 Apr;16(1):221-249. doi: 10.1007/s12561-023-09395-5. Epub 2023 Nov 4.
3
The impact of cancer metastases on COVID-19 outcomes: A COVID-19 and Cancer Consortium registry-based retrospective cohort study.癌症转移对 COVID-19 结局的影响：COVID-19 和癌症联盟注册处基于回顾性队列研究。
Cancer. 2024 Jun 15;130(12):2191-2204. doi: 10.1002/cncr.35247. Epub 2024 Feb 20.
4
Factors influencing COVID-19 mortality among cancer patients: A Brazilian multi-institutional study.影响癌症患者 COVID-19 死亡率的因素：巴西多机构研究。
PLoS One. 2023 Dec 21;18(12):e0295597. doi: 10.1371/journal.pone.0295597. eCollection 2023.
5
Impact of Cancerous Pulmonary Involvement on Outcomes in COVID-19 Patients.癌症肺部受累对COVID-19患者预后的影响。
Cureus. 2023 Apr 17;15(4):e37671. doi: 10.7759/cureus.37671. eCollection 2023 Apr.
6
Hematological- and Immunological-Related Biomarkers to Characterize Patients with COVID-19 from Other Viral Respiratory Diseases.用于区分新型冠状病毒肺炎患者与其他病毒性呼吸道疾病患者的血液学和免疫学相关生物标志物
J Clin Med. 2022 Jun 21;11(13):3578. doi: 10.3390/jcm11133578.
7
Preclinical Evidence Indicates the Pharmacological Targets and Mechanisms of Mogroside V in Patients With Ovarian Cancer and Coronavirus Disease 2019.临床前证据表明，罗汉果苷 V 可作为卵巢癌和 2019 年冠状病毒病患者的治疗靶点和作用机制。
Front Endocrinol (Lausanne). 2022 Apr 6;13:845404. doi: 10.3389/fendo.2022.845404. eCollection 2022.

本文引用的文献

1
The immuno-oncological challenge of COVID-19.COVID-19 的免疫肿瘤学挑战。
Nat Cancer. 2020 Oct;1(10):946-964. doi: 10.1038/s43018-020-00122-3. Epub 2020 Oct 2.
2
Severity of COVID-19 in Cancer patients versus patients without Cancer: A Propensity Score Matching Analysis.癌症患者与非癌症患者中新冠病毒疾病（COVID-19）的严重程度：一项倾向得分匹配分析
J Cancer. 2021 Apr 24;12(12):3558-3565. doi: 10.7150/jca.54205. eCollection 2021.
3
COVID-19 in Cancer Patients, Risk Factors for Disease and Adverse Outcome, a Population-Based Study From Norway.癌症患者中的COVID-19、疾病和不良结局的风险因素，一项基于挪威人群的研究
Front Oncol. 2021 Mar 25;11:652535. doi: 10.3389/fonc.2021.652535. eCollection 2021.
4
VEGF-C mediates tumor growth and metastasis through promoting EMT-epithelial breast cancer cell crosstalk.VEGF-C 通过促进 EMT-上皮型乳腺癌细胞串扰来介导肿瘤生长和转移。
Oncogene. 2021 Feb;40(5):964-979. doi: 10.1038/s41388-020-01539-x. Epub 2020 Dec 9.
5
COVID-19-Induced Modifications in the Tumor Microenvironment: Do They Affect Cancer Reawakening and Metastatic Relapse?新冠病毒感染引起的肿瘤微环境改变：它们会影响癌症复发和转移复发吗？
Front Oncol. 2020 Oct 26;10:592891. doi: 10.3389/fonc.2020.592891. eCollection 2020.
6
COVID-19: a potential driver of immune-mediated breast cancer recurrence?COVID-19：是否会成为免疫介导型乳腺癌复发的潜在驱动因素？
Breast Cancer Res. 2020 Oct 30;22(1):117. doi: 10.1186/s13058-020-01360-0.
7
Pulmonary and pleural metastasis mimicking COVID-19 infection in stage IV ovarian cancer: a case report.IV期卵巢癌中酷似新型冠状病毒肺炎感染的肺和胸膜转移：1例报告
Tumori. 2020 Dec;106(6):NP73-NP75. doi: 10.1177/0300891620952851. Epub 2020 Sep 22.
8
COVID-19 in cancer patients: risk, clinical features, and management.癌症患者中的 COVID-19：风险、临床特征和管理。
Cancer Biol Med. 2020 Aug 15;17(3):519-527. doi: 10.20892/j.issn.2095-3941.2020.0289.
9
Cancer and Risk of COVID-19 Through a General Community Survey.癌症与新冠病毒感染风险：基于一般社区调查
Oncologist. 2021 Jan;26(1):e182-5. doi: 10.1634/theoncologist.2020-0572. Epub 2020 Sep 7.
10
COVID-19 in patients with lung cancer.肺癌患者中的 COVID-19。
Ann Oncol. 2020 Oct;31(10):1386-1396. doi: 10.1016/j.annonc.2020.06.007. Epub 2020 Jun 17.